Elucidating the precise pharmacological mechanism of action (MOA) of naturally transpiring compounds can be challenging. Though Tarselli et al. (60) made the first de novo artificial pathway to conolidine and showcased this naturally transpiring compound correctly suppresses responses to both chemically induced and inflammation-derived pain, the pharmacologic focus on https://alvau851tkg7.glifeblog.com/profile